259 related articles for article (PubMed ID: 26935290)
21. Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
Jin X; Sun Y; Yang H; Li J; Yu S; Chang X; Lu Z; Chen J
PLoS One; 2015; 10(4):e0125515. PubMed ID: 25905463
[TBL] [Abstract][Full Text] [Related]
22. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA.
He X; Zheng Z; Li J; Ben Q; Liu J; Zhang J; Ji J; Yu B; Chen X; Su L; Zhou L; Liu B; Yuan Y
Carcinogenesis; 2012 Mar; 33(3):555-62. PubMed ID: 22223849
[TBL] [Abstract][Full Text] [Related]
23. The role of regucalcin in bone homeostasis: involvement as a novel cytokine.
Yamaguchi M
Integr Biol (Camb); 2014 Mar; 6(3):258-66. PubMed ID: 24458249
[TBL] [Abstract][Full Text] [Related]
24. Exogenous regucalcin suppresses the growth of human liver cancer HepG2 cells in vitro.
Yamaguchi M; Murata T
Oncol Rep; 2018 Jun; 39(6):2924-2930. PubMed ID: 29620227
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity.
Ma Q; Wu H; Xiao Y; Liang Z; Liu T
Int J Oncol; 2020 Apr; 56(4):1025-1033. PubMed ID: 32319558
[TBL] [Abstract][Full Text] [Related]
26. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
[TBL] [Abstract][Full Text] [Related]
28. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
31. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
32. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
33. Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells.
Yamaguchi M; Murata T; Ramos JW
Oncology; 2022; 100(7):399-412. PubMed ID: 35340010
[TBL] [Abstract][Full Text] [Related]
34. Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells.
Yamaguchi M; Murata T
Tissue Cell; 2020 Dec; 67():101447. PubMed ID: 33137709
[TBL] [Abstract][Full Text] [Related]
35. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of regucalcin suppresses apoptotic cell death in cloned normal rat kidney proximal tubular epithelial NRK52E cells: change in apoptosis-related gene expression.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2005 Dec; 96(6):1274-85. PubMed ID: 16167335
[TBL] [Abstract][Full Text] [Related]
37. c-Fos/ERK promotes the progression from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma.
You L; Ren X; Du Y; Zhao W; Cui M; Chen G; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3413-3420. PubMed ID: 27748943
[TBL] [Abstract][Full Text] [Related]
38. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
[TBL] [Abstract][Full Text] [Related]
39. Role of regucalcin in cell nuclear regulation: involvement as a transcription factor.
Yamaguchi M
Cell Tissue Res; 2013 Nov; 354(2):331-41. PubMed ID: 23793546
[TBL] [Abstract][Full Text] [Related]
40. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.
Swidnicka-Siergiejko AK; Gomez-Chou SB; Cruz-Monserrate Z; Deng D; Liu Y; Huang H; Ji B; Azizian N; Daniluk J; Lu W; Wang H; Maitra A; Logsdon CD
Oncogene; 2017 Jun; 36(22):3149-3158. PubMed ID: 27991926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
